XML 34 R6.htm IDEA: XBRL DOCUMENT v3.19.3
Consolidated Statements of Changes in Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Total
Preferred Equity
Common Stock
Surplus
Retained Earnings
Retained Earnings
Series C Preferred Stock
Retained Earnings
Series D Preferred Stock
Retained Earnings
Series E Preferred Stock
Accumulated Other Comprehensive Income (Loss)
Treasury Stock
Beginning balance at Dec. 31, 2017 $ 3,237,443 $ 159,929 $ 1,618 $ 1,338,722 $ 1,934,696       $ (62,758) $ (134,764)
Comprehensive income                    
Net income 69,456       69,456          
Other comprehensive income (loss) (31,177)               (31,177)  
Adoption of new accounting standards (13,738)               (13,738)  
Comprehensive income 24,541                  
Common stock issued                    
Stock-based compensation plans, net 10,691     (7,665) 20,136         (1,780)
Acquisition of Bank Mutual 481,688   134 390,258           91,296
Purchase of common stock returned to authorized but unissued (26,480)   (11) (26,469)            
Purchase of treasury stock (5,240)                 (5,240)
Cash dividends                    
Common stock ($0.15 per share in 2018 and $0.17 per share in 2019) (25,710)       (25,710)          
Preferred stock(a) [1] (2,339)       (2,339)          
Purchase of preferred stock (78) (76)     (2)          
Stock-based compensation expense, net 3,675     3,675            
Tax Act reclassification 13,654       13,654          
Change in accounting principle 84       84          
Other 771       771          
Ending balance at Mar. 31, 2018 3,712,699 159,853 1,741 1,698,521 2,010,746       (107,673) (50,488)
Beginning balance at Dec. 31, 2017 3,237,443 159,929 1,618 1,338,722 1,934,696       (62,758) (134,764)
Comprehensive income                    
Net income 244,578                  
Other comprehensive income (loss) (72,762)               (72,762)  
Comprehensive income 171,816                  
Cash dividends                    
Proceeds from Issuance of Preferred Stock and Preference Stock 97,315                  
Change in accounting principle                 (84)  
Ending balance at Sep. 30, 2018 3,797,038 256,716 1,752 1,709,078 2,128,490       (135,520) (163,478)
Cash dividends                    
Decrease Adjustment Options RSA and RSU       561            
Increase Adjustment Options, RSA and RSU         272         289
Preferred Stock, Dividends, Per Share, Cash Paid           $ 0.3828125 $ 0.3359375      
Beginning balance at Mar. 31, 2018 3,712,699 159,853 1,741 1,698,521 2,010,746       (107,673) (50,488)
Comprehensive income                    
Net income 89,192       89,192          
Other comprehensive income (loss) (12,215)               (12,215)  
Comprehensive income 76,977                  
Common stock issued                    
Stock-based compensation plans, net 5,456     1,455 (485)         4,486
Acquisition of Bank Mutual 6,720   3 6,717            
Purchase of common stock returned to authorized but unissued (6,595)   (3) (6,592)            
Purchase of treasury stock (477)                 (477)
Cash dividends                    
Common stock ($0.15 per share in 2018 and $0.17 per share in 2019) (26,107)       (26,107)          
Preferred stock(a) [1] (2,329)       (2,329)          
Common stock warrants exercised 0   10 (10)            
Purchase of preferred stock (459) (452)     (6)          
Stock-based compensation expense, net 4,497     4,497            
Other (139)       (139)          
Ending balance at Jun. 30, 2018 3,770,244 159,401 1,751 1,704,587 2,070,872       (119,888) (46,479)
Comprehensive income                    
Net income 85,929       85,929          
Other comprehensive income (loss) (15,631)               (15,631)  
Comprehensive income 70,298                  
Common stock issued                    
Stock-based compensation plans, net [2] 1,246     (129) (289)         1,664
Purchase of treasury stock (118,663)                 (118,663)
Cash dividends                    
Common stock ($0.15 per share in 2018 and $0.17 per share in 2019) (25,614)       (25,614)          
Preferred stock(a) [1],[3] (2,409)       (2,409)          
Proceeds from Issuance of Preferred Stock and Preference Stock 97,315 97,315                
Common stock warrants exercised 0   1 (1)            
Stock-based compensation expense, net 4,620     4,620            
Ending balance at Sep. 30, 2018 3,797,038 256,716 1,752 1,709,078 2,128,490       (135,520) (163,478)
Cash dividends                    
Preferred Stock, Dividends, Per Share, Cash Paid               $ 0.3671875    
Beginning balance at Dec. 31, 2018 3,780,888 256,716 1,752 1,712,615 2,181,414       (124,972) (246,638)
Comprehensive income                    
Net income 86,686       86,686          
Other comprehensive income (loss) 21,597               21,597  
Comprehensive income 108,283                  
Common stock issued                    
Stock-based compensation plans, net 7,045     (32,220)           39,265
Purchase of treasury stock (37,467)                 (37,467)
Cash dividends                    
Common stock ($0.15 per share in 2018 and $0.17 per share in 2019) (28,183)       (28,183)          
Preferred stock(a) [4] (3,801)       (3,801)          
Stock-based compensation expense, net 9,397     9,397            
Other (293)       (293)          
Ending balance at Mar. 31, 2019 3,835,870 256,716 1,752 1,689,792 2,235,824       (103,375) (244,840)
Beginning balance at Dec. 31, 2018 3,780,888 256,716 1,752 1,712,615 2,181,414       (124,972) (246,638)
Comprehensive income                    
Net income 254,686                  
Other comprehensive income (loss) 88,020               88,020  
Comprehensive income 342,706                  
Cash dividends                    
Proceeds from Issuance of Preferred Stock and Preference Stock 0                  
Ending balance at Sep. 30, 2019 3,920,855 256,716 1,752 1,713,971 2,341,158       (36,953) (355,791)
Cash dividends                    
Preferred Stock, Dividends, Per Share, Cash Paid               $ 0.3671875    
Beginning balance at Mar. 31, 2019 3,835,870 256,716 1,752 1,689,792 2,235,824       (103,375) (244,840)
Comprehensive income                    
Net income 84,661       84,661          
Other comprehensive income (loss) 44,311               44,311  
Comprehensive income 128,972                  
Common stock issued                    
Stock-based compensation plans, net 827     (211)           1,038
Purchase of treasury stock (40,433)                 (40,433)
Cash dividends                    
Common stock ($0.15 per share in 2018 and $0.17 per share in 2019) (27,776)       (27,776)          
Preferred stock(a) [4] (3,801)       (3,801)          
Stock-based compensation expense, net 6,134     6,134            
Ending balance at Jun. 30, 2019 3,899,794 256,716 1,752 1,695,715 2,288,909       (59,063) (284,235)
Comprehensive income                    
Net income 83,339       83,339          
Other comprehensive income (loss) 22,111               22,111  
Comprehensive income 105,450                  
Common stock issued                    
Stock-based compensation plans, net 1,198     12,561           (11,363)
Purchase of treasury stock (60,193)                 (60,193)
Cash dividends                    
Common stock ($0.15 per share in 2018 and $0.17 per share in 2019) (27,289)       (27,289)          
Preferred stock(a) [4] (3,801)       (3,801)          
Stock-based compensation expense, net 5,696     5,696            
Ending balance at Sep. 30, 2019 $ 3,920,855 $ 256,716 $ 1,752 $ 1,713,971 $ 2,341,158       $ (36,953) $ (355,791)
[1]
(b) Series C, $0.3828125 per share and Series D, $0.3359375 per share.
[2]
(a) As previously disclosed in the Corporation's 2018 Annual Report on Form 10-K, an adjustment was made to the September 30, 2018 stockholders' equity balances related to the grant and vesting of options, restricted stock awards, and restricted stock units awarded. This adjustment decreased Surplus approximately $561,000, increased Retained Earnings approximately $272,000, and increased Treasury Stock approximately $289,000. The reclassification had no impact on earnings, expenses, or total stockholders' equity.
[3]
(c) Series E, $0.3671875 per share.
[4]
(a) Series C, $0.3828125 per share; Series D, $0.3359375 per share; and Series E, $0.3671875 per share.